Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Otorhinolaryngology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 75 articles:
HTML format
Text format



Single Articles


    September 2017
  1. BLUM MURPHY M, Xiao L, Patel VR, Maru DM, et al
    Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30953.
    PubMed     Text format     Abstract available


  2. SABA NF
    Refining the predictors of outcome in patients with resectable esophageal cancer.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30952.
    PubMed     Text format    


    August 2017
  3. GRABOYES EM, Garrett-Mayer E, Ellis MA, Sharma AK, et al
    Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30939.
    PubMed     Text format     Abstract available


  4. ZUMSTEG ZS, Luu M, Yoshida EJ, Kim S, et al
    Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30933.
    PubMed     Text format     Abstract available


  5. ALBERGOTTI WG, Jordan J, Anthony K, Abberbock S, et al
    A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Cancer. 2017;123:3132-3140.
    PubMed     Text format     Abstract available


  6. ROBIN TP, Jones BL, Gordon OM, Phan A, et al
    A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Cancer. 2017;123:3040-3049.
    PubMed     Text format     Abstract available


  7. BHATIA AK, Lee JW, Pinto HA, Jacobs CD, et al
    Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
    Cancer. 2017 Aug 7. doi: 10.1002/cncr.30920.
    PubMed     Text format     Abstract available


    July 2017
  8. SANDMAEL JA, Bye A, Solheim TS, Stene GB, et al
    Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: A pilot randomized trial.
    Cancer. 2017 Jul 31. doi: 10.1002/cncr.30901.
    PubMed     Text format     Abstract available


  9. CRAMER JD, Speedy SE, Ferris RL, Rademaker AW, et al
    National evaluation of multidisciplinary quality metrics for head and neck cancer.
    Cancer. 2017 Jul 20. doi: 10.1002/cncr.30902.
    PubMed     Text format     Abstract available


  10. AN Y, Park HS, Kelly JR, Stahl JM, et al
    The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:2762-2772.
    PubMed     Text format     Abstract available


  11. CHANDRASEKHARAPPA SC, Chinn SB, Donovan FX, Chowdhury NI, et al
    Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30802.
    PubMed     Text format     Abstract available


    June 2017
  12. LEE AWM, Tung SY, Ng WT, Lee V, et al
    A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30850.
    PubMed     Text format     Abstract available


  13. DAVID JM, Ho AS, Luu M, Yoshida EJ, et al
    Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30843.
    PubMed     Text format     Abstract available


  14. WANG FH, Wang Y, Sun GP, Chen JH, et al
    Efficacy and safety of recombinant human lymphotoxin-alpha derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30845.
    PubMed     Text format     Abstract available


  15. KONG L, Zhang Y, Hu C, Guo Y, et al
    Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Cancer. 2017;123:2258-2267.
    PubMed     Text format     Abstract available


  16. LIN WC, Ding YF, Hsu HL, Chang JH, et al
    Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
    Cancer. 2017 Jun 13. doi: 10.1002/cncr.30823.
    PubMed     Text format     Abstract available


  17. ALI SM, Yao M, Yao J, Wang J, et al
    Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30781.
    PubMed     Text format     Abstract available


    May 2017
  18. MALM IJ, Fan CJ, Yin LX, Li DX, et al
    Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:1768-1777.
    PubMed     Text format     Abstract available


  19. GOEPFERT RP, Hutcheson KA, Lewin JS, Desai NG, et al
    Complications, hospital length of stay, and readmission after total laryngectomy.
    Cancer. 2017;123:1760-1767.
    PubMed     Text format     Abstract available


  20. LV JW, Chen YP, Huang XD, Zhou GQ, et al
    Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30775.
    PubMed     Text format     Abstract available


  21. PAI SI, Faquin WC
    Programmed cell death ligand 1 as a biomarker in head and neck cancer.
    Cancer. 2017 May 4. doi: 10.1002/cncy.21872.
    PubMed     Text format    


  22. NAIK KB, Liu Y, Goodman M, Gillespie TW, et al
    Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30763.
    PubMed     Text format     Abstract available


  23. FAKHRY C, Westra WH, Wang SJ, van Zante A, et al
    The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Cancer. 2017;123:1566-1575.
    PubMed     Text format     Abstract available


    April 2017
  24. ZUMSTEG ZS, Lok BH, Ho AS, Drill E, et al
    The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Cancer. 2017;123:1345-1353.
    PubMed     Text format     Abstract available


  25. BONGIOVANNI M, Mermod M, Canberk S, Saglietti C, et al
    Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Cancer. 2017 Apr 3. doi: 10.1002/cncy.21860.
    PubMed     Text format     Abstract available


  26. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Text format     Abstract available


    March 2017
  27. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    PubMed     Text format     Abstract available


  28. HAJEK M, Sewell A, Kaech S, Burtness B, et al
    TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30570.
    PubMed     Text format     Abstract available


  29. CHEN T, Zhang J, Chen Z, Van Waes C, et al
    Genetic alterations in TRAF3 and CYLD that regulate nuclear factor kappaB and interferon signaling define head and neck cancer subsets harboring human papillomavirus.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30659.
    PubMed     Text format    


  30. BRANDLER TC, Zhou F, Liu CZ, Cho M, et al
    Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Cancer. 2017 Mar 10. doi: 10.1002/cncy.21848.
    PubMed     Text format     Abstract available


    February 2017
  31. LIU Z, Chang ET, Liu Q, Cai Y, et al
    Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30643.
    PubMed     Text format     Abstract available


  32. GRABOYES EM, Garrett-Mayer E, Sharma AK, Lentsch EJ, et al
    Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30651.
    PubMed     Text format     Abstract available


  33. ZEVALLOS JP, Mazul AL
    The complex relation between race, sex, and human papillomavirus status in head and neck cancer.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30619.
    PubMed     Text format    


  34. HUANG J, Fogg M, Wirth LJ, Daley H, et al
    Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
    Cancer. 2017 Feb 21. doi: 10.1002/cncr.30541.
    PubMed     Text format     Abstract available



  35. Immunotherapy drug improves survival for patients with head and neck cancer.
    Cancer. 2017;123:545.
    PubMed     Text format    


  36. TABERNA M, Inglehart RC, Pickard RK, Fakhry C, et al
    Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer.
    Cancer. 2017 Feb 14. doi: 10.1002/cncr.30564.
    PubMed     Text format     Abstract available


  37. ZHAO L, Dias-Santagata D, Sadow PM, Faquin WC, et al
    Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21839.
    PubMed     Text format     Abstract available


  38. GOYAL L, Zheng H, Yurgelun MB, Abrams TA, et al
    A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncr.30571.
    PubMed     Text format     Abstract available


  39. GRABOYES EM, Zhan KY, Garrett-Mayer E, Lentsch EJ, et al
    Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2017 Feb 9. doi: 10.1002/cncr.30586.
    PubMed     Text format     Abstract available


  40. MANYAM BV, Garsa AA, Chin RI, Reddy CA, et al
    A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2017 Feb 7. doi: 10.1002/cncr.30601.
    PubMed     Text format     Abstract available


  41. YEN YC, Chang JH, Lin WC, Chiou JF, et al
    Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Cancer. 2017 Feb 2. doi: 10.1002/cncr.30565.
    PubMed     Text format     Abstract available


    January 2017
  42. WONG TH, Skanthakumar T, Nadkarni N, Nguyen HV, et al
    Survival of patients with head and neck squamous cell carcinoma by housing subsidy in a tiered public housing system.
    Cancer. 2017 Jan 30. doi: 10.1002/cncr.30557.
    PubMed     Text format     Abstract available


  43. JABBOUR J, Milross C, Sundaresan P, Ebrahimi A, et al
    Education and support needs in patients with head and neck cancer: A multi-institutional survey.
    Cancer. 2017 Jan 12. doi: 10.1002/cncr.30535.
    PubMed     Text format     Abstract available


  44. CHUANG SL, Su WW, Chen SL, Yen AM, et al
    Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers.
    Cancer. 2017 Jan 5. doi: 10.1002/cncr.30517.
    PubMed     Text format     Abstract available


  45. HUTCHESON KA, Barrow MP, Barringer DA, Knott JK, et al
    Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation.
    Cancer. 2017;123:62-70.
    PubMed     Text format     Abstract available


  46. SHER DJ, Rusthoven CG, Khan SA, Fidler MJ, et al
    National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:273-282.
    PubMed     Text format     Abstract available


    December 2016
  47. PEZZI TA, Mohamed AS, Sheu T, Blanchard P, et al
    Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30493.
    PubMed     Text format     Abstract available


  48. ZUMSTEG ZS, Kim S, David JM, Yoshida EJ, et al
    Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30508.
    PubMed     Text format     Abstract available


  49. PENG H, Chen L, Li WF, Guo R, et al
    Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30520.
    PubMed     Text format     Abstract available


  50. RAMAKODI MP, Devarajan K, Blackman E, Gibbs D, et al
    Integrative genomic analysis identifies ancestry-related expression quantitative trait loci on DNA polymerase beta and supports the association of genetic ancestry with survival disparities in head and neck squamous cell carcinoma.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30457.
    PubMed     Text format     Abstract available


  51. BAUMAN JE, Cohen E, Ferris RL, Adelstein DJ, et al
    Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30449.
    PubMed     Text format     Abstract available


  52. BISHOP JA, French CA, Ali SZ
    Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
    Cancer. 2016;124:901-908.
    PubMed     Text format     Abstract available


    October 2016
  53. TAJUDEEN BA, Taylor ZD, Garritano J, Cheng H, et al
    Dynamic optical contrast imaging as a novel modality for rapidly distinguishing head and neck squamous cell carcinoma from surrounding normal tissue.
    Cancer. 2016 Oct 20. doi: 10.1002/cncr.30338.
    PubMed     Text format     Abstract available


  54. STOKES WA, Jones BL, Bhatia S, Oweida AJ, et al
    A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.
    Cancer. 2016 Oct 11. doi: 10.1002/cncr.30382.
    PubMed     Text format     Abstract available


    September 2016
  55. TAYLOR LJ, Greenberg CC, Lidor AO, Leverson GE, et al
    Utilization of surgical treatment for local and locoregional esophageal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2016 Sep 28. doi: 10.1002/cncr.30368.
    PubMed     Text format     Abstract available


  56. BEADLE BM, Liao KP, Giordano SH, Garden AS, et al
    Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Cancer. 2016 Sep 23. doi: 10.1002/cncr.30350.
    PubMed     Text format     Abstract available


  57. CHAU NG, Haddad RI
    Antiangiogenic agents in head and neck squamous cell carcinoma: Tired of going solo.
    Cancer. 2016 Sep 20. doi: 10.1002/cncr.30352.
    PubMed     Text format    


  58. JIMENO A, Posner MR, Wirth LJ, Saba NF, et al
    A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Sep 20. doi: 10.1002/cncr.30317.
    PubMed     Text format     Abstract available


    August 2016
  59. MAZUL AL, Taylor JM, Divaris K, Weissler MC, et al
    Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
    Cancer. 2016 Aug 29. doi: 10.1002/cncr.30312.
    PubMed     Text format     Abstract available


  60. JIMENO A, Machiels JP, Wirth L, Specenier P, et al
    Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30256.
    PubMed     Text format     Abstract available


  61. WARD MC, Reddy CA, Adelstein DJ, Koyfman SA, et al
    Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis.
    Cancer. 2016 Aug 9. doi: 10.1002/cncr.30214.
    PubMed     Text format     Abstract available


  62. NAGHAVI AO, Echevarria MI, Grass GD, Strom TJ, et al
    Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30212.
    PubMed     Text format     Abstract available


    July 2016
  63. DIVI V, Harris J, Harari PM, Cooper JS, et al
    Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30204.
    PubMed     Text format     Abstract available


  64. HORNE ZD, Glaser SM, Vargo JA, Ferris RL, et al
    Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Cancer. 2016;122:2021-30.
    PubMed     Text format     Abstract available


    June 2016
  65. GARDEN AS, Fuller CD, Rosenthal DI, William WN Jr, et al
    Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2016;122:1702-7.
    PubMed     Text format     Abstract available


    May 2016
  66. LIN CC, Fedewa SA, Prickett KK, Higgins KA, et al
    Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.
    Cancer. 2016 May 31. doi: 10.1002/cncr.30122.
    PubMed     Text format     Abstract available


  67. WEISS JM, Bagley S, Hwang WT, Bauml J, et al
    Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma.
    Cancer. 2016 May 19. doi: 10.1002/cncr.30067.
    PubMed     Text format     Abstract available


  68. RETTIG EM, D'Souza G, Thompson CB, Koch WM, et al
    Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    Cancer. 2016 May 16. doi: 10.1002/cncr.30005.
    PubMed     Text format     Abstract available


  69. BIRON VL, Kostiuk M, Isaac A, Puttagunta L, et al
    Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Cancer. 2016;122:1544-51.
    PubMed     Text format     Abstract available


  70. CRACCHIOLO JR, Baxi SS, Morris LG, Ganly I, et al
    Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cancer. 2016;122:1523-32.
    PubMed     Text format     Abstract available


  71. PATEL MA, Blackford AL, Rettig EM, Richmon JD, et al
    Rising population of survivors of oral squamous cell cancer in the United States.
    Cancer. 2016;122:1380-7.
    PubMed     Text format     Abstract available


    March 2016
  72. ARMENIAN SH, Bhatia S
    Looking back to inform the future: Lesson learned from survivors of childhood cancer.
    Cancer. 2016;122:678-80.
    PubMed     Text format    


  73. FRIEDMAN DN, Chou JF, Oeffinger KC, Kleinerman RA, et al
    Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
    Cancer. 2016;122:773-81.
    PubMed     Text format     Abstract available


    February 2016
  74. PAN JJ, Ng WT, Zong JF, Chan LL, et al
    Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Cancer. 2016;122:546-58.
    PubMed     Text format     Abstract available


  75. FRAKES JM, Naghavi AO, Demetriou SK, Strom TJ, et al
    Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Cancer. 2016;122:634-41.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: